Intratumoral injection of rhenium-188 microspheres into an animal model of hepatoma

Journal of Nuclear Medicine

Volumn 39, Issue 10, 1998, Pages 1752-1757

  Wang, Shyh Jen ^a   Lin, Wan Yu ^b   Chen, Min Nan ^b   Chi, Ching Shiang ^b   Chen, Jung Ta ^b   Ho, William L ^b   Hsieh, Bor Tsung ^b   Shen, Lie Hang ^b   Tsai, Zei Tsan ^b   Ting, Gann ^b   Mirzadeh, Saed ^b   Knapp Jr , Furn F ^b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Biodistribution; Hepatoma; Intratumoral injection; Microsphere; Rhenium 188

Indexed keywords

MICROSPHERE; RHENIUM 188;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; GAMMA RADIATION; HALF LIFE TIME; INTRATUMORAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RAT; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

ANIMALS; FEMALE; INJECTIONS, INTRALESIONAL; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICROSPHERES; RADIOISOTOPES; RATS; RATS, SPRAGUE-DAWLEY; RHENIUM; TISSUE DISTRIBUTION;

EID: 0031714739     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gray BN, Burton MA, Kelleher DK, Andersen J, Klemp P. Selective internal radiation (SIR) therapy for treatment of liver metastases: measurement of response rate. J Surg Oncol 1989;42:192-196.
2. Houle S, Yip TK, Shepherd FA. Hepatocellular carcinoma: pilot trial of treatment with Y-90 microsphere. Radiology 1989;172:857-860.
3. Anderson JH, Goldberg JA, Bessernt RG. Glass yttrium-90 microspheres for patients with colorectal liver metastases. Radiother Oncol 1992;25:137-139.
4. Yumoto Y, Jinno K, Inatsuki S. Treatment of hepatocellular carcinoma by transcatheter hepatic arterial injection of radioactive iodized oil solution. Cancer Chemother Pharmacol 1992;31(suppl):S128-S136.
5. Raoul JI, Bretagne JF, Caucanas JP. Internal radiation therapy for hepatocellular carcinoma, results of a French multicentre phase II trial of transarterial injection of iodine 131-labeled lipiodol. Cancer 1992;69:346-352.
6. Leung WT, Lau WY, Ho S, et al. Selective internal radiation therapy with intra-arterial iodine-131-lipiodol in inoperable hepatocellular carcinoma. J Nucl Med 1994;35: 1313-1318.
7. Yan ZP, Lin G, Zhao HY, Dong YH. An experimental study and clinical pilot trials on yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer. Cancer 1993;72:3210-3215.
8. Nakhgevany KB, Mobini J, Bassett JG, Miller E. Nonabsorbable radioactive material in the treatment of carcinomas by local injection. Cancer 1988;61:931-940.
9. Wang SJ, Lin WY, Chen MN, Shen LH, Tsai ZT, Ting G. Preparation and biodistribution of Y-90 lipiodol in rats following hepatic arterial injection. Eur J Nucl Med 1995;22:233-236.
10. Wang SJ, Lin WY, Chen MN, et al. Biodistribution of rhenium-188 lipiodol infused via the hepatic artery of rats with hepatic tumours. Eur J Nucl Med 1996;23:13-17.
11. Tian JH, Xu BX, Zhang JM, Dong BW, Liang P, Wang XD. Ultrasound-guided internal radiotherapy using Y-90 glass microsphere for liver malignancies. J Nucl Med 1996;37:958-963.
12. Callahan AP, Rice DE, Knapp FF Jr. Availability of Re-188 from a tungsten-188/ Re188 generator system for therapeutic applications [Abstract]. J Nucl Med 1987;28: 657.
13. Callahan AP, Rice DE, Knapp FF Jr. Rhenium-188 for therapeutic applications from an alumna based tungsten-188/Re-188 radionuclide generator. Nucl Compact Eur Am Commun Nucl Med 1989;20:3-6.
14. Ehrhardt G, Ketring AP, Turpin TA, Razavi MS, Vanderherden J-L, Fritzberg AR. An improved tungsten-188/Re-188 generator for radiotherapeutic application. J Nucl Med 1987;28:656-657.
15. 131I-19-iodocholesterol: the pitfalls of using tissue concentration data: the author's reply. J Nucl Med 1975;16:248-249.
16. Loevinger R, Budinger T, Watson E. MIRD primer for absorbed dose calculation. New York: Society of Nuclear Medicine, 1988.
17. Cloutier R, Smith S, Watson E, Snyder W, Warger G. Dose to the fetus from radionuclides in the bladder. Health Phys 1973;25:147-161.
18. Stabin MG. MIRDOSE. Personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996;37:538-546.
19. Culter SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis 1958;8:699-712.
20. Breslow N. A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika 1970;57:579-594.
21. 131I-ethiodol on a patient with hepatocellular carcinoma: therapeutic feasibility study. Clin Nucl Med 1986;11:514-517.
22. Fox RA, Klemp PF, Egan G, Mina LL, Burton MA, Gray BN. Dose distribution following selective internal radiation therapy. Int J Radiat Oncol Biol Phys 1991;21: 463-467.
23. Callahan AP, Rice DE, Knapp FF Jr. Availability of rhenium-188 from a tungsten-188/Re188 generator system for therapeutic applications [Abstract]. J Nucl Med 1987;28:657p.
24. Mantravadi RVP, Spigos DG, Karesh SM. Intra-arterial P-32 Chromic phosphate for the prevention of postoperative liver metastases in high risk colorectal cancer patients. Radiology 1983;148:555-559.
25. Ho S, Lau WY, Leung WT. Ultrasound guided internal radiotherapy using yttrium-90 glass microspheres for liver malignancies [Letter]. J Nucl Med 1997;38:1169.